Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 2
1946 8
1947 3
1948 2
1949 3
1950 3
1951 1
1952 1
1975 2
1976 1
1979 1
1980 1
1982 2
1986 1
1989 1
1991 2
1992 1
1994 1
1995 2
1996 2
1997 5
1999 1
2000 2
2001 4
2002 2
2003 4
2005 3
2006 3
2008 2
2009 4
2010 1
2011 4
2012 13
2013 5
2014 2
2015 12
2016 5
2017 8
2018 6
2019 8
2020 4
2021 6
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

138 results
Results by year
Filters applied: . Clear all
Page 1
Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma.
Posey AD Jr, Schwab RD, Boesteanu AC, Steentoft C, Mandel U, Engels B, Stone JD, Madsen TD, Schreiber K, Haines KM, Cogdill AP, Chen TJ, Song D, Scholler J, Kranz DM, Feldman MD, Young R, Keith B, Schreiber H, Clausen H, Johnson LA, June CH. Posey AD Jr, et al. Among authors: stone jd. Immunity. 2016 Jun 21;44(6):1444-54. doi: 10.1016/j.immuni.2016.05.014. Immunity. 2016. PMID: 27332733 Free PMC article.
Monitoring Neuromuscular Performance in Military Personnel.
Merrigan JJ, Stone JD, Thompson AG, Hornsby WG, Hagen JA. Merrigan JJ, et al. Among authors: stone jd. Int J Environ Res Public Health. 2020 Dec 7;17(23):9147. doi: 10.3390/ijerph17239147. Int J Environ Res Public Health. 2020. PMID: 33297554 Free PMC article. Review.
Effect of ACTN3 Polymorphism on Self-reported Running Times.
Kreutzer A, Martinez CA, Kreutzer M, Stone JD, Mitchell JB, Oliver JM. Kreutzer A, et al. Among authors: stone jd. J Strength Cond Res. 2019 Jan;33(1):80-88. doi: 10.1519/JSC.0000000000002949. J Strength Cond Res. 2019. PMID: 30431530
Lipid haemagglutinins.
STONE JD. STONE JD. Aust J Exp Biol Med Sci. 1946 Sep;24(3):197-205. doi: 10.1038/icb.1946.30. Aust J Exp Biol Med Sci. 1946. PMID: 20273975 No abstract available.
Breaking tolerance with engineered class I antigen-presenting molecules.
Parks CA, Henning KR, Pavelko KD, Hansen MJ, Van Keulen VP, Reed BK, Stone JD, Schrum AG, Gil D, Kranz DM, Bordner AJ, Barry MA, Pease LR. Parks CA, et al. Among authors: stone jd. Proc Natl Acad Sci U S A. 2019 Feb 19;116(8):3136-3145. doi: 10.1073/pnas.1807465116. Epub 2019 Feb 6. Proc Natl Acad Sci U S A. 2019. PMID: 30728302 Free PMC article.
138 results